SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 14D9 - Solicitation, recommendation statements
SEC Accession No. 0001206774-09-000188
Filing Date
2009-02-06
Accepted
2009-02-06 11:14:20
Documents
7
Filing Date Changed
2009-02-06

Document Format Files

Seq Description Document Type Size
1 SOLICITATION/RECOMMENDATION STATEMENTS avigen_sc14d9.htm SC 14D9 73283
2 LETTER TO STOCKHOLDERS OF AVIGEN, DATED FEBRUARY 6, 2009 exhibit99a-1.htm EX-99.A.1 11375
3 GRAPHIC exhibit99a-1x1x1.jpg GRAPHIC 5962
4 PRESS RELEASE OF AVIGEN, DATED FEBRUARY 6, 2009 exhibit99a-2.htm EX-99.A.2 13056
5 GRAPHIC exhibit99a-2x1x1.jpg GRAPHIC 5886
6 EXCERPTS FROM AVIGEN'S PROXY STATEMENT exhibit99e-1.htm EX-99.E.1 173014
7 MANAGEMENT TRANSITION PLAN, AS AMENDED OCTOBER 30, 2008 exhibit99e-2.htm EX-99.E.2 113059
  Complete submission text file 0001206774-09-000188.txt   402375
Mailing Address 1301 HARBOR BAY PARKWAY ALAMEDA CA 94502
Business Address 1301 HARBOR BAY PARKWAY . ALAMEDA CA 94502 5107487150
AVIGEN INC \DE (Filed by) CIK: 0000932903 (see all company filings)

IRS No.: 133647119 | State of Incorp.: DE | Fiscal Year End: 1121
Type: SC 14D9
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
Assistant Director 1

Mailing Address 1301 HARBOR BAY PARKWAY ALAMEDA CA 94502
Business Address 1301 HARBOR BAY PARKWAY . ALAMEDA CA 94502 5107487150
AVIGEN INC \DE (Subject) CIK: 0000932903 (see all company filings)

IRS No.: 133647119 | State of Incorp.: DE | Fiscal Year End: 1121
Type: SC 14D9 | Act: 34 | File No.: 005-48313 | Film No.: 09575242
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
Assistant Director 1